Two Onc Docs
Localized Non-Small Cell Lung Cancer 2023 UPDATE
Nov 13, 2023
In this podcast, the hosts provide an update on the treatment landscape of early stage and locally advanced Non-Small Cell Lung Cancer (NSCLC). They cover topics such as pathology, staging, local and systemic therapy options, and special scenarios. The importance of understanding histological markers, diagnostic tests, and biomarker mutational testing is highlighted. They also discuss the classification and treatment options for NSCLC based on stage, including surgical options, SBRT, and perioperative treatment. Adjuvant chemotherapy regimens and controversies surrounding postoperative radiation are also addressed.
11:51
AI Summary
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- The two histologies of Non-Small Cell Lung Cancer (NSCLC) discussed in the podcast are adenocarcinoma and squamous cell carcinoma.
- The treatment of NSCLC is divided into different categories based on the stage, with surgery, targeted therapies, chemotherapy, and immunotherapy being recommended.
Deep dives
Histologies of Non-Small Cell Lung Cancer
The two histologies discussed in this episode are adenocarcinoma and squamous cell carcinoma. Adenocarcinoma is positive for TTF1 and cytokaratin seven, while squamous cell carcinoma is positive for P63 and P40.
